Boardroom Alpha
Boardroom Alpha
BRKR · Amended Current Report (Form 8-K/A) · Filed May 29, 2026

Bruker Corp — Amended Current Report (Form 8-K/A)

Form
8-K/A
Filed
May 29, 2026
Period
May 21, 2026
Ticker
BRKR
Accession
0001193125-26-248280
Boardroom Alpha · Filing insights

Bruker amends 8-K to include Inline XBRL tagging; annual meeting elected Class II directors and approved compensation and auditor ratification.

About Bruker Corp
Market cap
$8.7B
1Y TSR
+17.8%
3Y TSR
−14.5%
Board grade
C+
Sector
Healthcare
CEO
Frank H Laukien
Last annual meeting: May 21, 2026 · View full Bruker Corp profile →
8-K/A

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K/A

(Amendment No. 1)

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 21, 2026

BRUKER CORPORATION

(Exact name of registrant as specified in its charter)

Delaware

000-30833

04-3110160

(State or other jurisdiction of

(Commission

(I.R.S. Employer

incorporation)

File number)

Identification No.)

40 Manning Road

Billerica, MA 01821

(Address of principal executive offices) (Zip Code)

(978) 663-3660

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

Trading Symbol(s)

Name of Each Exchange on Which Registered

Common Stock, $0.01 par value per share

BRKR

The Nasdaq Global Select Market

6.375% Mandatory Convertible Preferred Stock, Series A, $0.01 par value per share

 

BRKRP

 

The Nasdaq Global Select Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 


 

Explanatory Note

 

The sole purpose of this amendment on Form 8-K/A to the Registrant’s Current Report on Form 8-K filed on May 21, 2026 (the “Original Report”) is to include Inline XBRL data tagging which was inadvertently omitted on the cover page of the Original Report for the 6.375% Mandatory Convertible Preferred Stock, Series A, $0.01 par value per share. This filing does not otherwise modify or update in any way disclosures made in the Original Report.

 

Section 5 - Corporate Governance and Management

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

On May 21, 2026, Bruker Corporation (the “Company”) held its 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”). At the 2026 Annual Meeting, the Company’s stockholders voted upon the following three proposals, each of which is described in greater detail in the Company’s definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on April 10, 2026. The final vote results for each proposal were as follows:

 

Proposal No. 1 Election of Directors

The following director nominees were elected to serve as Class II members of the Company’s board of directors, each to serve for a three-year term until the Company’s 2029 Annual Meeting of Stockholders and until his or her respective successor is duly elected and qualified based on the following votes:

 

Nominees for Class II director:

 

For

 

Withheld

 

Broker Non-Votes

Laura A. Francis

 

136,149,316

 

4,841,094

 

6,193,485

John J. (Jack) Phillips

 

139,036,356

 

1,954,054

 

6,193,485

Hermann F. Requardt, Ph.D.

 

129,777,851

 

11,212,559

 

6,193,485

 

Proposal No. 2 Advisory Vote on the 2025 Compensation of Named Executive Officers

The proposal to approve, on an advisory basis, the 2025 compensation of the named executive officers as disclosed in the Company’s proxy statement for the 2026 Annual Meeting was approved based on the following votes:

 

For

 

Against

 

Abstain

 

Broker Non-Votes

127,190,553

 

5,748,270

 

60,390

 

6,193,485

 

Proposal No. 3 Ratification of the Appointment of Independent Registered Public Accounting Firm

The proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal year 2026 was approved based on the following votes:

For

 

Against

 

Abstain

138,544,738

 

618,216

 

29,744

 

 

 

 


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

BRUKER CORPORATION
(Registrant)

Date: May 29, 2026

By:

/s/ THOMAS M. BURES

Thomas M. Bures

Chief Accounting Officer

 

 

 

 

 


From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Bruker Corp (BRKR)

Reference

Frequently asked questions

When did Bruker Corp file this 8-K/A?
Bruker Corp (BRKR) filed this Amended Current Report (Form 8-K/A) with the SEC on May 29, 2026. The accession number assigned by EDGAR is 0001193125-26-248280.
What does an 8-K/A disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Bruker amends 8-K to include Inline XBRL tagging; annual meeting elected Class II directors and approved compensation and auditor ratification. This is Boardroom Alpha's one-line summary of the amended current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Bruker Corp's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K/A Bruker Corp has filed under CIK 1109354, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer